|
Real-time Estimate
Tradegate
13:00:07 14/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.899 EUR | -2.32% |
|
-10.45% | -47.19% |
| 09-09 | Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment | MT |
| 09-09 | Evotec Commences Early-stage Study of Potential Orthopoxvirus Therapy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVOTEC SE | Other Biotechnology & Medical Research | -3.03% | -10.45% | -47.19% | -51.61% | -93.60% | 612M |  | | |
- Stock Market
- Stocks
- EVT Stock
- Charts Evotec SE
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
